先天性肝血管瘤的自然病史研究
该回顾性注册研究纳入2004至2022年间96例先天性肝血管瘤婴儿,描述其临床表现、影像与组织学特征及管理,重点分析自然消退规律。结果显示32%产前诊断,23%发生心力衰竭,23%发生呼吸衰竭;12个月平均残留体积43%(95%CI 27%-60%),24个月16%(95%CI 0%-35%);
要点
- 先天性肝血管瘤与婴儿型肝血管瘤在临床、组织学及影像上均不同。
- 多数病变在24月龄时消退超过80%,药物治疗未改变消退时间。
- 需早期识别心衰、呼衰等并发症并复核错误诊断。
核心结论
- 先天性肝血管瘤是皮肤先天性血管瘤的肝脏对应病变,与婴儿型肝血管瘤不同。
- 多数病变在24月龄时消退超过80%,药物治疗未改变消退时间。
研究设计与样本
- 回顾性分析本院先天性肝血管瘤注册库中2004至2022年出生的先天性肝血管瘤患者。
- 共纳入96例婴儿,用椭球体公式计算血管瘤体积。
- 采用非线性回归广义估计方程、Kaplan-Meier曲线及logrank检验分析体积变化。
主要发现
- 32%产前诊断,23%发生心力衰竭,23%发生呼吸衰竭。
- 12个月平均残留体积43%(95%CI 27%-60%)。
- 24个月平均残留体积16%(95%CI 0%-35%)。
关键数值与推荐
- 12个月残留体积43%(95%CI 27%-60%)。
- 24个月残留体积16%(95%CI 0%-35%)。
临床怎么用
- 认识先天性肝血管瘤的自然消退规律有助于早期识别相关并发症。
- 药物治疗未显示改变消退时间,需据此评估干预必要性。
- 临床、影像与组织学特征有助于与婴儿型肝血管瘤鉴别并及时复核诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize the clinical presentation, radiologic and histologic findings, and management options for congenital hepatic hemangioma (HH) with a focus on describing its natural history and rate of involution. STUDY DESIGN: Retrospective review of patients in our HH registry with a congenital HH born between 2004 and 2022 was performed. HH volumes were calculated using the formula for an ellipsoid. Multiple analyses of HH volume change were performed using nonlinear regression with generalized estimating equations, Kaplan-Meier curves, and logrank test. RESULTS: We identified 96 infants with a congenital HH. Of these, 32% were diagnosed prenatally, 23% developed heart failure, and 23% developed respiratory failure. On average, patients demonstrated 43% residual HH volume at 12 months (95% confidence interval: 27%-60%) and 16% residual volume at 24 months (95% confidence interval: 0%-35%). No difference in time to 50% HH volume reduction between patients with and without medical therapy was observed (P = .894). CONCLUSION: Congenital HH represents the hepatic counterpart of the cutaneous congenital hemangioma and is clinically, histologically, and radiographically distinct from infantile HH. Most lesions reach >80% involution by 24 months of age with no differences in time to involution observed with medical therapy. A clear understanding of the clinical behavior and evolution of congenital HH is critical to early recognition of associated morbidity and prompt review of an incorrect diagnosis.
引用
- Ostertag-Hill CA, Fevurly RD, Kulungowski AM, et al. The Natural History of Congenital Hepatic Hemangiomas. J Pediatr. 2025. PMID: 40023218. doi:10.1016/j.jpeds.2025.114523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。